Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：293
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [41] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [42] Targeting the PD-1/PD-L1 interaction in nasopharyngeal carcinoma
    Johnson, David
    Ma, Brigette B. Y.
    ORAL ONCOLOGY, 2021, 113
  • [43] Augmenting Adoptive T-cell Immunotherapy by Targeting the PD-1/PD-L1 Axis
    Lai, Junyun
    Beavis, Paul A.
    Li, Jasmine
    Darcy, Phillip K.
    CANCER RESEARCH, 2021, 81 (23) : 5803 - 5805
  • [44] Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective
    Bertrand, Philippe
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 10878 - 10888
  • [45] Targeting the PD-1/PD-L1 Axis in Human Vitiligo
    Willemsen, Marcella
    Melief, Cornelis J. M.
    Bekkenk, Marcel W.
    Luiten, Rosalie M.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
    Bocanegra, Ana
    Blanco, Ester
    Fernandez-Hinojal, Gonzalo
    Arasanz, Hugo
    Chocarro, Luisa
    Zuazo, Miren
    Morente, Pilar
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 17
  • [47] Emerging role of ubiquitination/ deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
    Ding, Peng
    Ma, Zhiqiang
    Fan, Yizeng
    Feng, Yingtong
    Shao, Changjian
    Pan, Minghong
    Zhang, Yimeng
    Huang, Di
    Han, Jing
    Hu, Yi
    Yan, Xiaolong
    GENES & DISEASES, 2023, 10 (03) : 848 - 863
  • [48] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [49] PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
    Parvez, Adil
    Choudhary, Furqan
    Mudgal, Priyal
    Khan, Rahila
    Qureshi, Kamal A.
    Farooqi, Humaira
    Aspatwar, Ashok
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy
    Jun-hao Li
    Lu-jia Huang
    Hui-ling Zhou
    Yi-ming Shan
    Fang-min Chen
    Vesa-Pekka Lehto
    Wu-jun Xu
    Li-qiang Luo
    Hai-jun Yu
    Acta Pharmacologica Sinica, 2022, 43 : 2749 - 2758
12345